Customized more aggressive treatments should be given to patients with the worst prognosis. For most of the other breast patients, shorter and often milder treatment is also a humble victory in our daily struggle against cancer.
Jean-Claude Horiot, MD, PhD
Advertisement
Articles by Jean-Claude Horiot, MD, PhD
Advertisement
Latest Updated Articles
- Consider a Single Intraoperative Fraction for Patients Eligible for Hypofractionated Regimens?
Published: June 15th 2014 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
2
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
3
Tucatinib Regimen Improves PFS in HER2+ Metastatic Breast Cancer
4
Safety Strategies for GPRC5D-Directed and T-Cell Engager Therapies
5
